Detalhe da pesquisa
1.
Antimicrobial effect of Australian antibacterial essential oils as alternative to common antiseptic solutions against clinically relevant oral pathogens.
Clin Lab
; 61(1-2): 61-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25807639
2.
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.
J Exp Med
; 187(8): 1349-54, 1998 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-9547346
3.
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.
J Exp Med
; 191(4): 625-30, 2000 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-10684854
4.
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.
J Exp Med
; 187(2): 265-70, 1998 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-9432985
5.
Antibiotic resistance testing of the total implant-associated micro-flora and its pure isolates.
Eur J Med Res
; 12(3): 120-8, 2007 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-17507308
6.
Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library.
Cancer Res
; 61(5): 2055-61, 2001 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11280766
7.
Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Clin Cancer Res
; 2(4): 641-52, 1996 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9816214
8.
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+ T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer.
Oncoimmunology
; 4(7): e1017702, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26140248
9.
Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes.
Hum Gene Ther
; 9(1): 53-62, 1998 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9458242
10.
Induction of tumour cell lysis by a bispecific antibody recognising epidermal growth factor receptor (EGFR) and CD3.
Eur J Cancer
; 30A(8): 1103-7, 1994.
Artigo
em Inglês
| MEDLINE | ID: mdl-7654439
11.
Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
Int J Oncol
; 19(5): 983-9, 2001 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-11604998
12.
Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals.
Melanoma Res
; 6(6): 419-25, 1996 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-9013479
13.
WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation.
Leukemia
; 23(9): 1634-42, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19357702
14.
Induction of tumor-cell lysis by bi-specific antibody recognizing ganglioside GD2 and T-cell antigen CD3.
Int J Cancer
; 55(3): 465-70, 1993 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-8375931
15.
Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo.
Int J Cancer
; 66(4): 470-6, 1996 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-8635862
16.
Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A.
Int J Cancer
; 81(6): 979-84, 1999 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-10362148
17.
Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens.
Int J Cancer
; 66(2): 162-9, 1996 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-8603805
18.
Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma.
Int J Cancer
; 71(2): 142-7, 1997 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-9139833
19.
Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
Int J Cancer
; 59(6): 837-42, 1994 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-7989126
20.
Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
Eur J Immunol
; 26(11): 2613-23, 1996 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-8921947